SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Solders Göran)
 

Sökning: WFRF:(Solders Göran) > (2005-2009) > A novel NGFB point ...

A novel NGFB point mutation : a phenotype study of heterozygous patients

Minde, Jan (författare)
Umeå universitet,Ortopedi,Department of Orthopaedics, Gällivare Hospital, Gällivare, Sweden
Andersson, T (författare)
Karolinska Institutet
Fulford, M (författare)
Department of Internal Medicine, Gällivare Hospital, Gällivare, Sweden
visa fler...
Aguirre, M (författare)
Department of Clinical Neuroscience Section of Neurophysiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
Nennesmo, I (författare)
Karolinska Institutet
Remahl, I Nilsson (författare)
Department of Neurology, Karolinska University Hospital, Stockholm, Sweden
Svensson, Olle (författare)
Umeå universitet,Ortopedi
Holmberg, Monica (författare)
Umeå universitet,Medicinsk och klinisk genetik
Toolanen, Göran (författare)
Umeå universitet,Ortopedi
Solders, G (författare)
Karolinska Institutet
visa färre...
 (creator_code:org_t)
BMJ Publishing Group Ltd, 2009
2009
Engelska.
Ingår i: Journal of Neurology, Neurosurgery and Psychiatry. - : BMJ Publishing Group Ltd. - 0022-3050 .- 1468-330X. ; 80:2, s. 188-195
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • OBJECTIVE: A family with neurological findings similar to hereditary sensory and autonomic neuropathy type V having a point mutation in the nerve growth factor beta (NGFB) gene was recently described. The homozygous genotype gives disabling symptoms. The purpose of the present study was to evaluate the symptoms in heterozygous patients. METHODS: 26 patients heterozygous for the NGFB mutation (12 men, mean age 50 (13-90) years) were examined clinically and answered a health status questionnaire, including the Michigan Neuropathy Screening Instrument (MNSI). 28 relatives (15 men, mean age 44 (15-86) years) without the mutation served as controls in the clinical examination part. 23 of the heterozygotes were examined neurophysiologically and six heterozygous patients underwent a sural nerve biopsy. RESULTS: The heterozygous phenotype ranged from eight patients with Charcot arthropathy starting in adult age and associated with variable symptoms of neuropathy but without complete insensitivity to pain, anhidrosis or mental retardation, to 10 symptom free patients. There was no difference in MNSI between the young heterozygous cases (<55 years old) and the controls. Six of 23 heterozygous patients had impaired cutaneous thermal perception and 11 of 23 had signs of carpal tunnel syndrome. Sural nerve biopsies showed a moderate reduction of both small myelinated (Adelta) and unmyelinated (C) fibres. No apparent correlation of small fibre reduction to symptoms was found. CONCLUSIONS: The NGFB mutation in its heterozygous form results in a milder disease than in homozygotes, with a variable clinical picture, ranging from asymptomatic cases to those with Charcot arthropathy appearing in adult age. Particularly age, but perhaps lifestyle factors also, may influence the development of clinical polyneuropathy.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Ortopedi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Orthopaedics (hsv//eng)

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy